1. Home
  2. AX vs ELVN Comparison

AX vs ELVN Comparison

Compare AX & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Axos Financial Inc.

AX

Axos Financial Inc.

HOLD

Current Price

$91.87

Market Cap

5.0B

Sector

Finance

ML Signal

HOLD

Logo Enliven Therapeutics Inc.

ELVN

Enliven Therapeutics Inc.

HOLD

Current Price

$44.89

Market Cap

4.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AX
ELVN
Founded
1999
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.0B
4.2B
IPO Year
2004
2020

Fundamental Metrics

Financial Performance
Metric
AX
ELVN
Price
$91.87
$44.89
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
14
Target Price
★ $117.71
$74.42
AVG Volume (30 Days)
332.7K
★ 1.6M
Earning Date
10-29-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 14.13
3.17
EPS
★ 2.25
N/A
Revenue
★ $81,254,000.00
N/A
Revenue This Year
$11.96
N/A
Revenue Next Year
$9.49
N/A
P/E Ratio
$42.03
★ N/A
Revenue Growth
★ 23.51
N/A
52 Week Low
$74.89
$14.79
52 Week High
$105.74
$62.32

Technical Indicators

Market Signals
Indicator
AX
ELVN
Relative Strength Index (RSI) 60.21 61.80
Support Level $94.35 $44.18
Resistance Level $100.94 $47.88
Average True Range (ATR) 2.34 1.84
MACD 0.60 1.04
Stochastic Oscillator 68.62 99.42

Price Performance

Historical Comparison
AX
ELVN

About AX Axos Financial Inc.

Axos Financial Inc is a technology-driven, diversified financial services company. Its client-centric, technology-enabled services model provides secure and scalable banking, clearing and custody, and investment advisory solutions to retail and business customers. The Bank provides consumer and commercial banking products and services through its digital online and mobile banking platforms, low-cost distribution channels and affinity partners. It offers deposit and lending products to customers nationwide including consumer and business checking, savings, etc. Its segments are Banking Business Segment and the Securities Business Segment. Majority of income comes from Banking Business Segment- It distribute its loan products through its retail, correspondent and wholesale channels.

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

Share on Social Networks: